Authors: Vogel, GMT van Amsterdam, RGM van Dinther, TG Tromp, M Meuleman, DG

Citation: Gmt. Vogel et al., Pre-clinical pharmacological profile of the novel glycoconjugate Org 36764with both factor Xa and thrombin (IIa) inhibitory activities, THROMB HAEM, 84(4), 2000, pp. 611-620

Authors: Rewinkel, JBM Lucas, H van Galen, PJM Noach, ABJ van Dinther, TG Rood, AMM Jenneboer, AJSM van Boeckel, CAA

Citation: Jbm. Rewinkel et al., 1-aminoisoquinollne as benzamidine isoster in the design and synthesis of orally active thrombin inhibitors, BIOORG MED, 9(5), 1999, pp. 685-690

Authors: Rewinkel, JBM Lucas, H Smit, MJ Noach, ABJ van Dinther, TG Rood, AMM Jenneboer, AJSM van Boeckel, CAA

Citation: Jbm. Rewinkel et al., Design, synthesis and testing of amino-bicycloaryl based orally bioavailable thrombin inhibitors, BIOORG MED, 9(19), 1999, pp. 2837-2842

Authors: Buijsman, RC Basten, JEM van Dinther, TG van der Marel, GA van Boeckel, CAA van Boom, JH

Citation: Rc. Buijsman et al., Design and synthesis of a novel synthetic NAPAP-pentasaccharide conjugate displaying a dual antithrombotic action, BIOORG MED, 9(14), 1999, pp. 2013-2018